Impact of inhibitory KIR ligand mismatch and other variables on outcomes following myeloablative posttransplant cyclophosphamide-based T-cell-replete haploidentical bone marrow transplantation

Authors: Sarah Kayser, Emilia Salzmann-Manrique, Hubert Serve, Peter Bader, Jan-Henning Klusmann, Christian Seidl, Joachim Schwäble, Gesine Bug, Evelyn Ullrich

Source: Frontiers in Immunology, Vol 15 (2024)

Subject Terms: hematopoietic cell transplantation (HCT), T-cell-repleted haploidentical bone marrow transplantation (BMT), posttransplant cyclophosphamide (PTCy), hematological malignancies, inhibitory KIR ligand mismatch, recipient and donor variables, Immunologic diseases. Allergy, RC581-607

File Description: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fimmu.2024.1413927/full; https://doaj.org/toc/1664-3224

Access URL: https://doaj.org/article/0889d2ce43f248dda02d077347701039

Successful management of acute graft-versus-host disease with ibrutinib during cord blood transplantation for germline DDX41-mutated acute myeloid leukemia

Authors: Uchimura, Ayana ^a, Yasuda, Hajime ^{a, ∗}, Onagi, Hiroko ^b, Inano, Tadaaki ^a, Shirane, Shuichi ^a, Ishii, Midori ^a, Azusawa, Yoko ^e, Hamano, Yasuharu ^a, Eguchi, Hidetaka ^c, Arai, Masami ^d, Ando, Jun ^{a, e}, Ando, Miki ^a

Source: In Heliyon 30 January 2024 10(2)